Thrombotic Thrombocytopenic Purpura as a Cause of Stroke in a Young Person – a Clinical Case

Authors

  • Cristina Cândido Serviço de Medicina, Hospital de S. Bernardo - Centro Hospitalar de Setúbal, Setúbal, Portugal
  • Ana Farinha Serviço de Medicina, Hospital de S. Bernardo - Centro Hospitalar de Setúbal, Setúbal, Portugal
  • Ermelinda Pedroso Serviço de Medicina, Hospital de S. Bernardo - Centro Hospitalar de Setúbal, Setúbal, Portugal
  • Manuel Sousa Serviço de Medicina, Hospital de S. Bernardo - Centro Hospitalar de Setúbal, Setúbal, Portugal

DOI:

https://doi.org/10.24950/rspmi.876

Keywords:

Plasmapheresis, Purpura, Thrombotic Thrombocytopenic

Abstract

Thrombotic thrombocytopenic purpura is a rare disorder characterized by thrombocytopenia, microangiopathic hemolysis and occlusive ischemia, with the brain being the main affected organ. The
clinical approach taken in Emergency Departments, in the first hours
of a young adult with focal neurologic signs and suspect of stroke is
the immediate exclusion of pathologies that are contraindications to
thrombolysis, as for example, thrombotic thrombocytopenic purpura.
Until a few decades ago, thrombotic thrombocytopenic purpura was
a devastating disorder, of unknown etiology, almost universally fatal.
Currently, the prognosis of these patients improved significantly with
a better understanding of the disorder pathophysiology as well as
with the introduction of plasmapheresis at an early stage. The authors
report a clinical case in which the diagnosis of the thrombotic thrombocytopenic purpura at an early stage together with the access to plasmapheresis allowed good clinical results to be achieved.

Downloads

Download data is not yet available.

References

Leno C, Berciano J, Combarros O, Polo JM, Pascual J, Quintana F, et al. A prospective study of stroke in young adults in Cantabria,

Spain. Stroke. 1993;24:792-5.

BogousslavsK J, Van Melle G. Reglif: The Lausanne Stroke Register: analysis of 1000 consecutive patients with first stroke. Stroke 1988;

: 1083-92

Remuzzi G. HUS and TTP: variable expression of a single entity. Kidney Int. 1987; 32:292.

Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic

purpura. Kidney Int. 2001;60:831

Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, et al. Comparison of plasma exchange with plasma infusion in

the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991;325:393-7

Von Baeyer H. Plasmapheresis in thrombotic microangiopathyassociated syndromes: review of outcome data derived from clinical

trials and open studies. Ther Apher. 2002; 6:320

George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010; 116:4060

Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002; 347:589

Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. Arch Intern Med

; 36:89-93

Singer K, Bornstein FP, Wile SA. Thrombotic thrombocytopenic purpura: Hemorrhagic diathesis with generalized platelet thromboses.

Blood 1947;2:542-54

Symmers WSC. Thrombotic microangiopathic haemolytic anemia (thrombotic microangiopathy). Br Med J. 1952; 2:897-903)

Allford SL, Hunt BJ, Rose P, Machin SJ; Haemostasis and Thrombosis Task Force, British Committee for Standards in

Haematology. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol.

;120:556-73

Additional Files

Published

2015-03-31

How to Cite

1.
Cândido C, Farinha A, Pedroso E, Sousa M. Thrombotic Thrombocytopenic Purpura as a Cause of Stroke in a Young Person – a Clinical Case. RPMI [Internet]. 2015 Mar. 31 [cited 2024 Nov. 23];22(1):23-5. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/876

Issue

Section

Case Reports

Most read articles by the same author(s)